Introduction and Aims: The achievement of a pathologic complete response (pCR) after preoperative chemotherapy (PCT) is a validated surrogate end point for long term outcome. On the other side, patients with residual disease in the breast and/or axilla are an heterogeneous group with very different prognosis, including both patients with truly chemo-resistant disease as well as patients with an important tumor downstaging even if not in pCR. Aim of this analysis is to identify, in patients with residual disease, potential markers able to discriminate patients at higher risk of relapse. Patients and Methods:. The following parameters were evaluated on the surgical specimen in patients with less than pCR following PCT: residual breast disease...
INTRODUCTION:The locoregional recurrence (LRR) rate was reported as high as approximately 20% in sta...
Background: We aimed to predict disease-free survival (DFS) in patients who failed to achieve a path...
Systemic neoadjuvant chemotherapy (NCT) is a standard treatment for locally advanced breast cancer (...
Introduction and Aims: The achievement of a pathologic complete response (pCR) after preoperative ch...
Background: Preoperative chemotherapy (PCT) allows for in vivo testing of treatment effects on tumor...
BACKGROUND: Preoperative chemotherapy (PCT) allows for in vivo testing of treatment effects on tumor...
Background: The achievement of a pathologic complete response (pCR) after preoperative chemotherapy ...
Background: Tools able to predict pathological complete response (pCR) to preoperative chemotherapy ...
Purpose: Breast cancer is a heterogeneous disease, and newer technologies have identified different ...
Ki67 as a Predictor of Response and Long Term Purpose: Breast cancer is a heterogeneous disease, an...
Purpose: Preoperative chemotherapy (PCT) allows for a direct assessment of treatment effects on the ...
Background: The pathological complete response (pCR) after neoadjuvant chemotherapy is a surrogate m...
Purpose: Tumor stage and nodal status are the most important factors predicting locoregional recurre...
Despite remarkable improvements in breast cancer survival in the last decades, a proportion of patie...
PURPOSE: There is limited knowledge of risk factors for breast cancer recurrence within 2 years. Thi...
INTRODUCTION:The locoregional recurrence (LRR) rate was reported as high as approximately 20% in sta...
Background: We aimed to predict disease-free survival (DFS) in patients who failed to achieve a path...
Systemic neoadjuvant chemotherapy (NCT) is a standard treatment for locally advanced breast cancer (...
Introduction and Aims: The achievement of a pathologic complete response (pCR) after preoperative ch...
Background: Preoperative chemotherapy (PCT) allows for in vivo testing of treatment effects on tumor...
BACKGROUND: Preoperative chemotherapy (PCT) allows for in vivo testing of treatment effects on tumor...
Background: The achievement of a pathologic complete response (pCR) after preoperative chemotherapy ...
Background: Tools able to predict pathological complete response (pCR) to preoperative chemotherapy ...
Purpose: Breast cancer is a heterogeneous disease, and newer technologies have identified different ...
Ki67 as a Predictor of Response and Long Term Purpose: Breast cancer is a heterogeneous disease, an...
Purpose: Preoperative chemotherapy (PCT) allows for a direct assessment of treatment effects on the ...
Background: The pathological complete response (pCR) after neoadjuvant chemotherapy is a surrogate m...
Purpose: Tumor stage and nodal status are the most important factors predicting locoregional recurre...
Despite remarkable improvements in breast cancer survival in the last decades, a proportion of patie...
PURPOSE: There is limited knowledge of risk factors for breast cancer recurrence within 2 years. Thi...
INTRODUCTION:The locoregional recurrence (LRR) rate was reported as high as approximately 20% in sta...
Background: We aimed to predict disease-free survival (DFS) in patients who failed to achieve a path...
Systemic neoadjuvant chemotherapy (NCT) is a standard treatment for locally advanced breast cancer (...